Having a multidisciplinary team gives us deep & diverse expertise to tap across our discovery endeavors. This series shares those insights with you. Actionable insight. That is what’s needed to move from nontargeted discovery screenings to development of targeted clinical assays that can provide new diagnostics or guide drug development to success. Sapient’s Head of… Continue reading Experts On… Making Biomarker Discoveries Actionable